# ARBUTUS BIOPHARMA CORP (ABUS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ABUS/

- Reporting holders: 5
- Reported value: $40.3M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Two Seas Capital LP](https://holderbook.com/funds/1823138-two-seas-capital-lp/) | $38.9M | 8,143,994 | 0.4% | 20 |
| [Ledgewood Wealth Advisors, LLC](https://holderbook.com/funds/2064043-ledgewood-wealth-advisors-llc/) | $1.3M | 278,436 | 0.7% | 12 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $23.9K | 5,000 | 0.0% | 9 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $870 | 182 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $650 | 136 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $40.3M |
| Q2 2026 | 179 | $722.8M |
| Q1 2026 | 168 | $632.4M |
| Q4 2025 | 177 | $606.2M |
| Q3 2025 | 171 | $552.9M |
| Q2 2025 | 165 | $370.7M |
| Q1 2025 | 170 | $395.7M |
| Q4 2024 | 155 | $345.2M |
| Q3 2024 | 145 | $401.1M |
| Q2 2024 | 132 | $311.2M |
| Q1 2024 | 120 | $275.5M |
| Q4 2023 | 109 | $223.7M |